The G7 methodology agreed with COVAX takes the total support provided by a donor to COVAX in terms of unrestricted grant supports for COVAX's work and then calculates the dose equivalency based on that. For Canada, that $554 million in grant supports translates to the equivalent of 87 million doses procured and distributed by COVAX.
On March 21st, 2022. See this statement in context.